Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line

Neurosci Res. 2011 Apr;69(4):337-42. doi: 10.1016/j.neures.2010.12.020. Epub 2011 Jan 19.

Abstract

The neurodegenerative process in Parkinson's disease (PD) is accompanied by the presence of a neuroinflammatory response, which has been suggested as one of the principal components involved in PD progression. In this report we assessed the inflammatory potential of alpha-synuclein, a protein central to PD pathogenesis, released by neurons on the mouse microglia cell line BV-2. BV-2 cells were treated with conditioned medium isolated from normal SH-SY5Y cells and clones that over-express WT or mutant A53T alpha-synuclein. Conditioned medium isolated from over-expressing clones induced the transcription and release of pro-inflammatory cytokines. Treatment of SH-SY5Y alpha-synuclein over-expressing cells with MPP+, the active metabolite of the neurotoxin MPTP, increased the inflammatory response in BV-2 cells. In contrast, the direct exposure of BV-2 cells to MPP+ failed to induce an inflammatory response. These results support the hypothesis that WT and A53T alpha-synuclein has an important role in the initiation and maintenance of inflammation in PD, through the activation of a pro-inflammatory response in microglial cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blotting, Western
  • Cell Line
  • Culture Media, Conditioned / metabolism
  • Cytokines / biosynthesis
  • Gene Expression
  • Humans
  • Inflammation / immunology
  • Mice
  • Microglia / immunology*
  • Microglia / metabolism
  • Neurons / metabolism*
  • Reverse Transcriptase Polymerase Chain Reaction
  • alpha-Synuclein / immunology*
  • alpha-Synuclein / metabolism

Substances

  • Culture Media, Conditioned
  • Cytokines
  • alpha-Synuclein